Cinacalcet

Back to search

Molecule Structure

Scientific Name

Cinacalcet

Description of the Drug

Cinacalcet is a calcium sensing receptor agonist used to treat secondary hyperparathyroidism in chronic kidney disease and hypercalcemia in parathyroid carcinoma.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01012

Brand Name(s)

Sensipar

Company Owner(s)

Cipla Ltd, The Acme Laboratories Ltd, Alkem Laboratories Ltd, Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc, Piramal Healthcare Uk Ltd, Sun Pharmaceutical Industries Ltd, Accord Healthcare Inc, Aurobindo Pharma Ltd, Dr Reddys Laboratories Ltd, Hetero Labs Ltd Unit V

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Calcium sensing receptor SINGLE PROTEIN POSITIVE ALLOSTERIC MODULATOR CHEMBL1878

Unichem Links

SureChEMBL SCHEMBL71876
PharmGKB PA164776671
Human Metabolome Database HMDB0015147
DrugBank DB01012
PubChem: Thomson Pharma 14828105
PubChem 156419
LINCS LSM-5815
Nikkaji J1.645.239D
PDBe YP4
BindingDB 50416875
EPA CompTox Dashboard DTXSID8048286
DrugCentral 647
ChemicalBook CB5506688
Guide to Pharmacology 3308
rxnorm SENSIPAR CINACALCET CINACALCET HYDROCHLORIDE
ChEBI 48390
ZINC ZINC000001550499